SAB Biotherapeutics Appoints Katie Ellias to the Board of Directors - SAB Biotherapeutics (NASDAQ:SABSW), SAB Biotherapeutics (NASDAQ:SABS)

SIOUX FALLS, S.D., Nov. 20, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ:SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a fully-human anti-thymocyte

Related Keywords

Geneva ,Genè ,Switzerland ,Paris ,France General ,France ,Samuelj Reich ,Katie Ellias ,International Relations ,University Of Pennsylvania ,Wharton School ,Mckinsey Company ,Company Board Of Directors ,Medtronic ,Rd Fund ,Biotherapeutics Inc ,Exchange Commission ,Managing Director ,Veralox Therapeutics ,Endeavour Vision ,Sofinnova Partners ,Healthcare Management ,Political Science ,Executive Chairman ,Private Securities Litigation Reform Act ,